(+-)-alpha-Methyltryptamine → HCID 23113507, Verbindung
Reaktionsgleichung
[NH:1]1[C:9]2[C:4](=[CH:5][CH:6]=[CH:7][CH:8]=2)[C:3]([CH2:10][CH:11]([NH2:13])[CH3:12])=[CH:2]1.[F:14][C:15]1[CH:16]=[C:17]([CH:20]=[CH:21][CH:22]=1)[CH:18]=O>>[F:14][C:15]1[CH:16]=[C:17]([CH:18]2[C:2]3[NH:1][C:9]4[C:4](=[CH:5][CH:6]=[CH:7][CH:8]=4)[C:3]=3[CH2:10][CH:11]([CH3:12])[NH:13]2)[CH:20]=[CH:21][CH:22]=1Komponenten
3
Versuchsvorschrift
In addition, the compounds in Example 15(5) and Example 15(6) were prepared by separating diastereomer mixture which was obtained by reacting [2-(1H-indol-3-yl)-1-methylethyl]amine with 3-fluorobenzaldehyde, by column chromatography on silica gel.
Aufarbeitung
- customIn addition, the compounds in Example 15(5) and Example 15(6) were prepared
- customby separating diastereomer mixture which
- customwas obtained
Quellen und Nachweise
- ORD-Eintrag
- ord-60dec57d4e8548f48b41f1b46c358d0c
- Quelldatensatz
- uspto-grants-2011_01
- Patentnummer
- US07872133B2
Notizen zur Reaktion
Wird geladen…